Guillain-Barre syndrome following COVID-19 vaccination: a case report and an updated review.

ABSTRACT:

Background

Coronavirus disease-2019 (COVID-19) has caused a pandemic that has recently affected every aspect of life. Fortunately, many vaccines with high safety and efficacy profiles were developed timely to face this pandemic. In a very short time, billions of people were vaccinated. In the meantime, a wide range of neurological syndromes are being reported. Guillain-Barré syndrome (GBS) which is a rare immune-mediated post-infectious peripheral neuropathy was reported after both the COVID-19 infection itself and many types of its vaccines.

Methods

We are reporting a case of post-AstraZeneca vaccine GBS and reviewing the literature of all reported post-COVID-19 vaccines GBS till July 2021.

Results

29 adult patients were reported. Of them 58.6% were males. Their

SUBMITTER: Aly A 

PROVIDER: S-EPMC8864061 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature